Angelo Antonini Selected Research

Electrocoagulation (Electrocautery)

1/2022	European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies.
1/2022	European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo Antonini Research Topics

Disease

199	Parkinson Disease (Parkinson's Disease) 05/2024 - 11/2003
41	Dyskinesias (Dyskinesia) 02/2024 - 05/2006
19	Parkinsonian Disorders (Parkinsonism) 09/2023 - 11/2002
15	Cognitive Dysfunction 12/2023 - 05/2009
14	Dementia (Dementias) 12/2023 - 06/2007
13	Tremor (Tremors) 12/2023 - 08/2007
12	Movement Disorders (Movement Disorder) 12/2023 - 12/2007
9	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2023 - 09/2007
8	Pain (Aches) 03/2022 - 09/2008
7	COVID-19 12/2023 - 05/2020
6	Disease Progression 12/2019 - 12/2008
6	Gambling (Pathological Gambling) 06/2011 - 02/2008
4	Hallucinations (Hallucination) 12/2023 - 06/2007
4	Inflammation (Inflammations) 11/2023 - 01/2017
4	Deglutition Disorders (Dysphagia) 03/2022 - 01/2016
4	Fatigue 02/2022 - 01/2011
4	Multiple System Atrophy 01/2014 - 11/2002
3	Infections 12/2023 - 01/2017
3	Psychotic Disorders (Schizoaffective Disorder) 12/2023 - 09/2017
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2023 - 01/2010
3	Atrophy 12/2020 - 06/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2016
3	Sleep Wake Disorders 01/2020 - 01/2010
3	Orthostatic Hypotension (Postural Hypotension) 01/2017 - 01/2013
3	Corticobasal Degeneration 05/2013 - 01/2010
3	Heart Valve Diseases (Valvular Heart Disease) 10/2011 - 01/2007
3	Essential Tremor (Essential Tremors) 04/2010 - 04/2008
2	Virus Diseases (Viral Diseases) 12/2023 - 01/2022
2	Dystonic Disorders (Writer's Cramp) 01/2023 - 02/2011
2	Gliosis 01/2023 - 06/2010
2	Polyneuropathies (Polyneuropathy) 01/2019 - 05/2013
2	Edema (Dropsy) 02/2018 - 11/2016
2	Hemorrhage 01/2017 - 04/2010
2	Anhedonia 06/2015 - 07/2013
2	Hyperhomocysteinemia 01/2014 - 05/2009
1	Neuroblastoma 12/2023
1	Brain Diseases (Brain Disorder) 12/2023
1	Hypokinesia (Bradykinesia) 12/2023
1	Frailty 11/2023
1	Autonomic Nervous System Diseases (Dysautonomia) 09/2023
1	Dystonia (Limb Dystonia) 09/2023

Drug/Important Bio-Agent (IBA)

89	Levodopa (L Dopa)FDA LinkGeneric 01/2024 - 11/2003
30	Carbidopa (Lodosyn)FDA LinkGeneric 12/2023 - 07/2009
23	Dopamine Agonists (Dopamine Agonist)IBA 11/2023 - 05/2006
19	Dopamine (Intropin)FDA LinkGeneric 05/2024 - 07/2007
18	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2024 - 03/2006
16	Apomorphine FDA Link 12/2022 - 11/2003
14	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2008
9	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 05/2024 - 09/2007
7	opicaponeIBA 12/2023 - 01/2021
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2018
6	SynucleinsIBA 12/2023 - 01/2012
6	Antipsychotic Agents (Antipsychotics)IBA 09/2023 - 02/2006
6	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 03/2004
6	Pramipexole (Mirapex)FDA LinkGeneric 06/2015 - 09/2004
4	Phosphotransferases (Kinase)IBA 01/2024 - 03/2006
4	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2018
4	Cabergoline FDA LinkGeneric 06/2015 - 01/2007
3	Antidepressive Agents (Antidepressants)IBA 12/2023 - 05/2006
3	ioflupaneIBA 05/2021 - 08/2006
3	hydroxide ionIBA 01/2017 - 01/2013
3	rotigotine FDA Link 12/2013 - 01/2010
3	Pergolide (Permax)FDA Link 12/2011 - 01/2007
3	Leucine (L-Leucine)FDA Link 01/2007 - 03/2006
2	propylene diquat (PDQ(+))IBA 12/2022 - 09/2012
2	mesoglycanIBA 03/2022 - 11/2021
2	SuspensionsIBA 01/2021 - 04/2016
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 01/2021 - 04/2016
2	Amantadine (Aman)FDA LinkGeneric 12/2019 - 02/2015
2	LigandsIBA 07/2017 - 07/2008
2	salicylhydroxamic acid (SHAM)IBA 05/2016 - 11/2015
2	HomocysteineIBA 01/2014 - 05/2009
2	Tolcapone (Tasmar)FDA Link 12/2008 - 02/2008
2	Sertraline (Zoloft)FDA LinkGeneric 08/2006 - 05/2006
1	Coffee FDA Link 05/2024
1	Caffeine (No Doz)FDA LinkGeneric 05/2024
1	Dopamine Agents (Dopaminergic Agents)IBA 02/2024
1	Zonisamide (Zonegran)FDA LinkGeneric 02/2024
1	Neuroprotective AgentsIBA 12/2023
1	ProdrugsIBA 12/2023
1	TransferasesIBA 11/2023
1	catechol (pyrocatechol)IBA 11/2023
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 11/2023
1	Serotonin (5 Hydroxytryptamine)IBA 09/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2023

Therapy/Procedure

60	Therapeutics 04/2024 - 11/2003
48	Deep Brain Stimulation 04/2024 - 11/2003
14	Activities of Daily Living (ADL) 01/2024 - 03/2010
6	Palliative Care (Palliative Therapy) 12/2023 - 01/2021
6	Subcutaneous Infusions 12/2023 - 11/2003
4	Wearable Electronic Devices 01/2023 - 01/2018
4	Gastrostomy 01/2021 - 06/2007
3	Denervation 10/2021 - 01/2010
3	Operative Surgical Procedures 05/2014 - 01/2007
2	Electrocoagulation (Electrocautery) 01/2022 - 01/2022
2	Cognitive Training 11/2017 - 05/2016
2	Transcranial Direct Current Stimulation 05/2016 - 01/2016
2	Secondary Prevention 01/2012 - 11/2010
1	Continuity of Patient Care 12/2023